Pharma
First patient dosed in second phase I clinical trial of AT278 ultra-concentrated, ultra-rapid acting insulin candidate
Arecor Therapeutics plc, the biopharmaceutical group advancing today’s therapies to enable healthier lives, announces that the first patient has been dosed in its Phase I clinical trial investigating AT278, an ultra-rapid acting, ultra-concentrated (500 U/mL) insulin candidate, in Type ...
Oxford Drug Design and PhoreMost collaborate to advance novel cancer therapeutics discovery
Targeted protein degradation discovery programme to harness artificial intelligence to identify new E3 Ligase-based therapeutic strategies ...
March Cresset Newsletter
Explore the upcoming features within the upcoming Flare v7 software release, alongside a range of exciting news and updates in the Cresset March newsletter! ...
Lunch & Learn: Small Molecule Innovation
The world health demand is great, for small molecule drugs that may one day drug the undruggable and feature superior pharmaceutical characteristics. PharmaLex examines the small molecule innovation opportunity and challenge. During this talk we will discuss the different regulatory pat...
Integrated AI Synthesis Prediction in Drug Discovery
We are delighted to join forces with PostEra to discuss how AI, machine learning and other computational tools can support the drug discovery process, by bringing you feasible synthetic routes to your target compounds. Join us 13 April 16:00 BST| 11:00 EDT| 8:00 PDT to: Discover m...
Cancer teams at Genomics England show significant new developments in long-read sequencing
Genomics is changing the future of healthcare – from improving diagnosis and more targeted treatments, to making healthcare systems more efficient. Using cutting-edge analytics, the cancer team at Genomics England have analysed a first batch of over 100 whole genome sequences generated...
Collaboration for new therapies: maximizing funding and innovation
How do the public and private sectors collaborate on European medicines R&D and how can we increase the synergies that stem from the involvement of these sectors? ...
New business marketing materials delivered by Sable&Hawkes
Cambridge-based brand, design and content marketing company Sable&Hawkes have been commissioned to deliver business marketing materials for Echion Technologies, the world’s leading supplier of niobium-based anode materials for Li-ion batteries. ...
Cambridge ‘REVERT’ dementia clinic in international spotlight
Thirty-six people who feared they may be suffering from dementia have received life-changing surgery since the opening of a new clinic at Addenbrooke’s Hospital, an international conference will hear on Monday (13 March). ...
Breaking the time capsule: Life Sciences in 2010 and today
CRA’s Life Sciences Practice team recently analyzed past predictions of industry trends and compared them to what has occurred in the past decade, identified influencing factors and success drivers of these trends, and applied them to current industry predictions to outline what needs t...